BusinessAXIM® Biotech Expands Advisory Board With Psychiatry Specialist – Dr. Ilya ReznikBy Nasdaq OMXDec 13, 2016, 2:00 PM UTC
BusinessAXIM® Biotech Receives Medical Ethical Committee Approval to Begin IBS Trial for Canchew Plus® CBDGumBy Nasdaq OMXDec 6, 2016, 2:00 PM UTC
BusinessAXIM® Biotech Files IP Application on Propietary Method to Extract High-Purity THCBy Nasdaq OMXNov 29, 2016, 2:01 PM UTC
BusinessAXIM® Biotech Files IP Application on Propietary Method to Extract High-Purity THCBy Nasdaq OMXNov 29, 2016, 2:01 PM UTC
BusinessAxim® Biotechnologies, Inc. Donates Flagship CanChew Gum to U.S. Pain Foundation to Help Chronic Pain SufferersBy Nasdaq OMXNov 22, 2016, 2:00 PM UTC
BusinessETST Announces 60-Patient Clinical Prelaunch Study for its MSN-2 Medical Device for the Diagnosis of Chlamydia & Gonorrhea, ETST Elects Dr. Michel Aubé as New CEO & CSO, and Nickolas Tabraue as President.By Nasdaq OMXNov 21, 2016, 1:15 PM UTC
BusinessAXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for IBS Symptoms in Suffering PatientsBy Nasdaq OMXNov 1, 2016, 1:01 PM UTC
BusinessAXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for IBS Symptoms in Suffering PatientsBy Nasdaq OMXNov 1, 2016, 1:01 PM UTC
